Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals

Cost Effectiveness of Pre– vs Post–Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals

(2018) Sumeyye Samur et al.   Clinical Gastroenterology and Hepatology

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

(2018) Z. M. Younossi et al.   JOURNAL OF VIRAL HEPATITIS

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece

(2017) Ilias Gountas et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

(2017) Rakesh Aggarwal et al.   PLoS One

Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden

(2016) Zobair Younossi et al.   GASTROENTEROLOGY

The Impact of Age on Fibrosis Progression in Chronic Hepatitis C Patients

(2016) I. Gountas et al.   JOURNAL OF HEPATOLOGY

Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus

(2016) Z. M. Younossi et al.   JOURNAL OF VIRAL HEPATITIS

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States

(2016) Zobair M. Younossi et al.   MEDICINE

Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity

(2016) Issah Younossi et al.   PSYCHOSOMATICS

Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population

(2016) Harinder S. Chahal et al.   JAMA Internal Medicine

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

(2015) C. Estes et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2

(2015) E. Gane et al.   JOURNAL OF VIRAL HEPATITIS

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

(2015) A. Hatzakis et al.   JOURNAL OF VIRAL HEPATITIS

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

(2015) V. Saraswat et al.   JOURNAL OF VIRAL HEPATITIS

Thresholds for the cost–effectiveness of interventions: alternative approaches

(2015) Elliot Marseille et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

(2014) H. Razavi et al.   JOURNAL OF VIRAL HEPATITIS

Strategies to manage hepatitis C virus (HCV) disease burden

(2014) H. Wedemeyer et al.   JOURNAL OF VIRAL HEPATITIS

Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma

(2014) Athina Chounta et al.   LIVER INTERNATIONAL

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Cost-Of-Illness Analysis of Hepatitis C in Greece

(2013) K. Athanasakis et al.   VALUE IN HEALTH

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

(2012) Homie Razavi et al.   HEPATOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Economic burden of hepatitis C-associated diseases in the United States

(2011) A. C. El Khoury et al.   JOURNAL OF VIRAL HEPATITIS

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY